Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

China Punishes 357 Officials in Tainted Vaccine Sales

By AP | April 14, 2016

BEIJING (AP) — China has fired or demoted 357 local government officials for poor performance as it deals with the fallout from a nationwide public health scandal over the sale of improperly handled vaccines.

Along with punishing the officials, Beijing has ordered measures to tighten supervision over the storage and distribution of vaccines, the official Xinhua News Agency and other state media outlets reported Thursday, citing a document from the China’s Cabinet, the State Council.

In all, 192 criminal cases have been filed nationwide and 202 people detained as part of the sweeping probe, which found 45 groups involved in “improper vaccine trading,” the media reports said.

Drug wholesalers will also be forbidden from selling vaccines, and vaccines will be traced from production to usage, with special rules enacted for refrigeration and transport, the reports said.

The scandal erupted last month when China’s Food and Drug Administration announced it had discovered nine companies were reselling improperly stored or expired vaccines, meaning an unknown number of children may have received shots that provided no health benefits and could cause side effects.

The government says all the suspect doses were produced under proper conditions and did not contain impurities that could cause diseases. However, vaccines past their use-by dates or improperly refrigerated should be destroyed.

The vaccines involved fell into China’s second category of voluntary immunizations for rabies, hepatitis b and other diseases rather than those required for all children.

The revelations exposed loopholes in China’s public health oversight and a shadowy vaccine trade in which some government clinics did business with dubious middlemen.

The reports sparked an outcry among Chinese parents who say they face perennial fears over drug and food safety problems in China’s regulatory environment.

In one of the best-known cases, 300,000 children in 2008 consumed tainted infant milk formula, leading to six infant deaths and tens of thousands of hospitalizations.

China’s reputation for weak oversight of the domestic food and drug market has prompted Chinese parents to buy large quantities of infant formula while traveling overseas, especially to neighboring Hong Kong. Foreign cosmetics, health supplements and vitamins are also in hot demand.

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!


Filed Under: Drug Discovery

 

Related Articles Read More >

FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE